Arxiv:2006.16299V2 [Physics.Chem-Ph] 11 Sep 2020
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Methyl Vinyl Ketone Mvk
METHYL VINYL KETONE MVK CAUTIONARY RESPONSE INFORMATION 4. FIRE HAZARDS 7. SHIPPING INFORMATION 4.1 Flash Point: 30°F O.C. 20°F C.C. 7.1 Grades of Purity: 98.5+% Common Synonyms Liquid Colorless to light yellow Strong irritating 4.2 Flammable Limits in Air: 2.1% 15.6% 7.2 Storage Temperature: Cool ambient 3-Buten-2-one odor 4.3 Fire Extinguishing Agents: Dry 7.3 Inert Atmosphere: No requirement chemical, alcohol foam, carbon dioxide 7.4 Venting: Pressure-vacuum Mixes with water. Irritating vapor is produced. 4.4 Fire Extinguishing Agents Not to Be Used: Water may be ineffective. 7.5 IMO Pollution Category: Currently not available Evacuate. 4.5 Special Hazards of Combustion 7.6 Ship Type: Currently not available KEEP PEOPLE AWAY. AVOID CONTACT WITH LIQUID. Products: Not pertinent 7.7 Barge Hull Type: Currently not available Avoid inhalation. 4.6 Behavior in Fire: Vapor is heavier than Wear rubber overclothing (including gloves). air and may travel a considerable Shut off ignition sources. Call fire department. 8. HAZARD CLASSIFICATIONS distance to a source of ignition and flash Stay upwind. Use water spray to ``knock down'' vapor. back. At elevated temperatures (fire 8.1 49 CFR Category: Flammable liquid Notify local health and pollution control agencies. conditions) polymerization may take Protect water intakes. 8.2 49 CFR Class: 3 place in containers, causing violent 8.3 49 CFR Package Group: II rupture. Unburned vapors are very FLAMMABLE. irritating. 8.4 Marine Pollutant: No Fire Containers may explode in fire. 8.5 NFPA Hazard Classification: Flashback along vapor trail may occur. -
Medication List
Medication List Walgreens Plus™ members receive discounts on thousands of generic and brand-name medications included on this Medication List, which is divided into two sections, “Value Priced” Medications and “Discounted” Medications*. The price for a medication identified as “Value-Priced” is listed below: Get savings up to 85% off Cash Prices • 30-day-supply drugs cost $5 (tier 1), $10 (tier 2) or $15 (tier 3) on Atorvastatin (generic Lipitor) and • 90-day-supply drugs cost $10 (tier 1), $20 (tier 2) or $30 (tier 3) Rosuvastatin (generic Crestor) †† The Discounted Medications section lists the discounts offered to Walgreens Plus members on other generic and brand-name medications not included in the Value-Priced Medication section. The price for a medication is based on its tier and whether it is a 30-day or 90-day supply†. There may be an additional cost for quanities greater than those listed. This discount prescription pricing applies only to Walgreen Plus members on prescriptions purchased in select Walgreens stores that are not billed to insurance and/or used in combination with other health or pharmacy benefit programs. For further details, see your pharmacist or Walgreens.com/Plus. VALUE GENERICS NAPROXEN 250MG TAB 2 60 180 Antifungal NAPROXEN 500MG TAB 2 60 180 Quantity NAPROXEN 375MG TAB 2 60 180 Drug Name Tier 30 90 NAPROXEN DR 500MG TAB 3 60 180 FLUCONAZOLE 150MG TAB 2 1 3 TERBINAFINE 250MG TAB 2 30 90 Asthma Quantity Antiviral Drug Name Tier 30 90 Quantity ALBUTEROL 0.083% INH SOLN 25X3ML 2 75 225 Drug Name Tier 30 90 AMINOPHYLLINE -
Fagron Advanced Derma Compatibility Table
Fagron Advanced Derma Compatibility table Legend Skin types Compatible combination for Oily skin Balanced skin Dehydrated skin Very dehydrated skin Affected skin Specific skin area 14/15 days 30 days 60 days OCCLUVAN™ EMOLIVAN™ VERSATILE™ VERSATILE™ NOURIVAN™ FITALITE™ NOURILITE™ SERAQUA™ NOURISIL™ SOLYDRA™ ESPUMIL™ RICH ANTIOX 90 days Especially recommended combination Compatible combination up to x% Combination not studied Combination not compatible API/DCI concentration(s) Common Aloe Vera Extract 0.5 to 10% 8% 5% Alpha Bisabolol 0.5 to 5% 1% 1% Ammonium Lactate 1 to 12% 10% 10% 8% Anthralin/Dithranol 0.05 to 3% Arginine Hydrochloride 2.5% Ascorbic Acid (Vitamin C) 5 to 15% 5% 10% Azelaic Acid 10 to 20% Benzoyl Peroxide 2.5 to 10% 5% Benzyl Benzoate 25% Betamethasone Dipropionate 0.05% Betamethasone Valerate 0.025 to 0.1% 0.05% Caffeine 1 to 2% Chamomile Extract 0.5 to 5% Ciclopirox Olamine 1% Clindamycin Hydrochloride 1 to 3% Clobetasol Propionate 0.05% Clotrimazole 1 to 2% Coal Tar Crude (Pix Lithanthracis) 1 to 10% Coal Tar Solution (Liquor Carbonis 5 to 20% Detergens) 10% 10% 10% Cyanocobalamin (Vitamin B12) 0.07% Desonide 0.05 to 0.1% Desoximetasone 0.25% Dexpanthenol 0.5 to 5% Diclofenac Sodium 3% Erythromycin 0.5 to 4% Finasteride 0.1% Fluocinolone Acetonide 0.01 to 0.1% Glycerol 0.5 to 20% 8% 5% Glycolic Acid 5 to 15% Hyaluronic Acid Sodium 0.2 to 2.5% Hydrocortisone 0.25 to 2.5% Hydrocortisone Acetate 0.25 to 2.5% Hydroquinone 2 to 4% Ketoconazole 2% Kojic Acid 1 to 4% Lactic Acid 1 to 20% 10% Lidocaine 0.5 to 10% 5% Lidocaine -
A Novel Series of Titanocene Dichloride Derivatives: Synthesis, Characterization and Assessment of Their
A novel series of titanocene dichloride derivatives: synthesis, characterization and assessment of their cytotoxic properties by Gregory David Potter A thesis submitted to the Department of Chemistry in conformity with the requirements for the degree of Doctor of Philosophy Queen’s University Kingston, Ontario, Canada May, 2008 Copyright © Gregory David Potter, 2008 Abstract Although cis-PtCl2(NH3)2 (cisplatin) has been widely used as a chemotherapeutic agent, its use can be accompanied by toxic side effects and the development of drug resistance. Consequently, much research has been focused on the discovery of novel transition metal compounds which elicit elevated cytotoxicities coupled with reduced toxic side effects and non-cross resistance. Recently, research in this lab has focused on preparing derivatives of titanocene dichloride (TDC), a highly active chemotherapeutic agent, with pendant alkylammonium groups on one or both rings. Earlier results have demonstrated that derivatives containing either cyclic or chiral alkylammonium groups had increased cytotoxic activities. This research therefore investigated a new series of TDC complexes focusing specifically on derivatives bearing cyclic and chiral alkylammonium groups. A library of ten cyclic derivatives and six chiral derivatives were synthesized and fully characterized. These derivatives have undergone in vitro testing as anti-tumour agents using human lung, ovarian, and cervical carcinoma cell lines (A549, H209, H69, H69/CP, A2780, A2780/CP and HeLa). These standard cell lines represent solid tumour types for which new drugs are urgently needed. The potencies of all of the Ti (IV) derivatives varied greatly (range from 10.8 μM - >1000 μM), although some trends were observed. In general, the dicationic analogues exhibited greater potency than the corresponding monocationic derivatives. -
Catalysis Science & Technology
Catalysis Science & Technology Accepted Manuscript This is an Accepted Manuscript, which has been through the Royal Society of Chemistry peer review process and has been accepted for publication. Accepted Manuscripts are published online shortly after acceptance, before technical editing, formatting and proof reading. Using this free service, authors can make their results available to the community, in citable form, before we publish the edited article. We will replace this Accepted Manuscript with the edited and formatted Advance Article as soon as it is available. You can find more information about Accepted Manuscripts in the Information for Authors. Please note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal’s standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains. www.rsc.org/catalysis Page 1 of 6 CatalysisPlease doScience not adjust & Technology margins Journal Name ARTICLE Hydrophenylation of internal alkynes with boronic acids catalysed by a Ni-Zn hydroxy double salt-intercalated Received 00th January 20xx, Accepted 00th January 20xx Manuscript DOI: 10.1039/x0xx00000x anionic rhodium(III) complex www.rsc.org/ Takayoshi Hara, 1 Nozomi Fujita, 1 Nobuyuki Ichikuni, 1 Karen Wilson, 2 Adam F. Lee, 2 and Shogo Shimazu* 1 3- [Rh(OH) 6] intercalated Ni–Zn mixed basic salts (Rh/NiZn) are efficient catalysts for the hydrophenylation of internal alkynes with arylboronic acids under mild conditions. -
Synthesis and Reactions of Ferrocene
R Carbon Synthesis and Reactions of Ferrocene R Carbon Carbon Contents Objectives 1 Introduction 1 Preparation of ferrocene 2 Acetylation of ferrocene 7 Preparation of [Fe(η-C5H5)(η-C6H6)]PF6 10 Reaction of [Fe(η-C5H5)(η-C6H6)] PF6 with nucleophiles 12 Manuscript prepared by Dr. Almas I. Zayya, Dr. A. Jonathan Singh and Prof. John L. Spencer. School of Chemical and Physical Sciences, Victoria University of Wellington, New Zealand. R Carbon Objectives Introduction The principal aims of these experiments are to The archetypal organometallic compound provide experience in the synthesis, isolation, ferrocene, [Fe(η-C5H5)2], is of historical importance purification and characterisation of organometallic since its discovery and structural characterisation compounds. Purification techniques include in the early 1950s sparked extensive research into distillation, sublimation, chromatography and the chemistry of metal sandwich compounds.1 crystallisation. The main characterisation Two of the chemists who first proposed the correct technique used in these experiments is 1H NMR structure of ferrocene (Figure 1), Geoffrey Wilkinson spectroscopy using the benchtop Spinsolve and Ernst Otto Fischer, were awarded the Nobel spectrometer. Furthermore, students will Prize in Chemistry in 1973 for their pioneering work also develop their synthetic skills using inert on the chemistry of sandwich complexes. atmosphere techniques. Ferrocene is an example of a π-complex in which interactions between the d-orbitals of the Fe2+ metal centre with the π-orbitals of the two planar - cyclopentadienyl ligands (C5H5 ) form the metal-ligand bonds. Thus, all the carbon atoms in the cyclopentadienyl rings are bonded equally to the central Fe2+ ion. Ferrocene exhibits aromatic properties and is thermally very stable. -
United States Patent Office Patented May 7, 1963
3,088,959 United States Patent Office Patented May 7, 1963 1. 2 or grouping of carbon atoms which is present in cyclo 3,088,959 pentadiene. This grouping is illustrated as PROCESS OF MAKENG CYCLOPENTADEENY NECKEL, NTROSYL COMPOUNDS Robert D. Feltham, Joseph F. Anzenberger, azad Jonatian T. Carrie, Pittsburgh, Pa., assignors to The Interaa tional Nickel Company, Inc., New York, N.Y., a corpo ration of Delaware No Drawing. FiRed Sept. 1, 1960, Ser. No. 53,374 The substituent groups on the cyclopentadiene moiety 6 Clains. (C. 260-439) 0. indicated as R, R2, R3, R and R5 are any one or more The present invention relates to the production of of hydrogen atoms, halogen atoms and/or organic groups nickel compounds and, more particularly, to the produc such as aliphatic groups, aromatic groups, alicyclic groups, tion of nickel nitrosyl compounds containing a group etc. The substituent groups can also bond at two posi having the cyclopentadienyl moiety. tions. Where this occurs, groups can substitute for adja Compounds such as cyclopentadienylnickel nitrosyl, 5 cent R groups, e.g., Ra and R3 and/or R4 and R5 to form methylcyclopentadienylnickel nitrosyl and other complex indene and other condensed ring structures. nitrosyl compounds containing a cyclopentadienyl-type As mentioned hereinbefore, when carrying out the proc group have been made. Such compounds have use as ess of the present invention, the reactants are reacted in gasoline additives. When such use is contemplated, it is the presence of a base. The base can advantageously be economically imperative that the compounds be produced 20 a nitrogen base or a phosphorus base or an alkoxide of a in good yield from the most readily available and inex metal having a strong hydroxide. -
Benzocaine, Lidocaine, Tetracaine)
The compounding professionals of LifeCare Pharmacy can prepare individualised therapies for a myriad of dermatological problems. Our compounding pharmacists continue to improve both the aesthetic and therapeutic aspects of customised medications, offering alternatives and advantages for dermatology. We can help you solve dermatological issues with customised formulations to meet your needs and preferences. Clear Face (Topical acne creams) Ingredients: Nicotinamide or Spironolactone topical Description: Emergence of resistant pathogens emphasizes the need for alternatives to antimicrobial agents for acne therapy. We can compound cosmetically-appealing customized formulations which can contain alternative medications to provide a synergistic effect for treatment of resistant acne. Topical nicotinamide is used in the treatment of inflammatory acne vulgaris; Topical spironolactone reduces sebum secretion rates in young adults. These alternatives to the oral tablets give the benefits of localized dispersion of the medication without the unwanted side effects of taking the oral tablets. Reference: Int J Dermatol 1995 Jun;34(6):434-7 Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne-vulgaris. Shalita AR, Smith JG, Parish LC, Sofman MS, Chalker DK Department of Dermatology, State University of New York, College of Medicine, Brooklyn, USA. J Dermatol 1996 Apr;23(4):243-6 Topical spironolactone reduces sebum secretion rates in young adults. Yamamoto A, Ito M Department of Dermatology, Niigata University School of Medicine, Japan. BLT Cream (Benzocaine, Lidocaine, Tetracaine) Ingredients: Benzocaine 20%, Lidocaine 6%, Tetracaine 4% Description: BLT Cream is commonly used to numb the area at which a patient will be undergoing laser hair removal. Particular areas that can be numbed include facial areas, and most general body areas. -
Dietary Supplements Compendium Volume 1
2015 Dietary Supplements Compendium DSC Volume 1 General Notices and Requirements USP–NF General Chapters USP–NF Dietary Supplement Monographs USP–NF Excipient Monographs FCC General Provisions FCC Monographs FCC Identity Standards FCC Appendices Reagents, Indicators, and Solutions Reference Tables DSC217M_DSCVol1_Title_2015-01_V3.indd 1 2/2/15 12:18 PM 2 Notice and Warning Concerning U.S. Patent or Trademark Rights The inclusion in the USP Dietary Supplements Compendium of a monograph on any dietary supplement in respect to which patent or trademark rights may exist shall not be deemed, and is not intended as, a grant of, or authority to exercise, any right or privilege protected by such patent or trademark. All such rights and privileges are vested in the patent or trademark owner, and no other person may exercise the same without express permission, authority, or license secured from such patent or trademark owner. Concerning Use of the USP Dietary Supplements Compendium Attention is called to the fact that USP Dietary Supplements Compendium text is fully copyrighted. Authors and others wishing to use portions of the text should request permission to do so from the Legal Department of the United States Pharmacopeial Convention. Copyright © 2015 The United States Pharmacopeial Convention ISBN: 978-1-936424-41-2 12601 Twinbrook Parkway, Rockville, MD 20852 All rights reserved. DSC Contents iii Contents USP Dietary Supplements Compendium Volume 1 Volume 2 Members . v. Preface . v Mission and Preface . 1 Dietary Supplements Admission Evaluations . 1. General Notices and Requirements . 9 USP Dietary Supplement Verification Program . .205 USP–NF General Chapters . 25 Dietary Supplements Regulatory USP–NF Dietary Supplement Monographs . -
Skin Lightening Medical Grade
MEDICAL GRADE SKIN LIGHTENING FADE-12 HAND & ARM CREAM INTENSIVE RECOVERY CREAM 1.76 oz. / 55 g. 1.7 oz. / 48 g. Advanced multi-active formula com- Contains a blend of active ingredients, Intensive Recovery Cream reduces sensi- bines 12 active ingredients including: tivity in the skin while increasing moisture skin lighteners, alpha hydroxy acids and levels and protecting against environ- botanical extracts resulting in hands mental damage. Specially formulates to which look years younger within weeks reduce irritation associates with the use of use. of alpha/beta hydroxy acids and retinoids. New EpHQuinone™ technology re- High purity extract specifcally developed sults in rapid removal of age spots for combating the irritation caused by AHA and hyperpigmentation and retinoids Contains 12 active ingredients, that Down regulates infammation enzymes to penetrates the skin and stimulates soothe the skin results Decreases Trans-Epidermal Water Loss EpHQuinone™ Interrupts the me- by 17% lanogenesis pathway at multiple points, resulting in rapid and effective Contains smart sugar that improves cell improvement in age spots and other communication for reducing stinging effect excess pigmentation. from AHA and increasing NMF (Natural Moisturizing Factor) on the skin DIRECTIONS DIRECTIONS Apply sparingly over hands and arms, Apply a generous amount to soothe allow product to absorb before applying irritated skin as needed. Allow to ab- Intensive Recovery Cream. Initial appli- sorb before applying additional prod- cation should be two to three -
Synthesis and Reactivity of Cyclopentadienyl Based Organometallic Compounds and Their Electrochemical and Biological Properties
Synthesis and reactivity of cyclopentadienyl based organometallic compounds and their electrochemical and biological properties Sasmita Mishra Department of Chemistry National Institute of Technology Rourkela Synthesis and reactivity of cyclopentadienyl based organometallic compounds and their electrochemical and biological properties Dissertation submitted to the National Institute of Technology Rourkela In partial fulfillment of the requirements of the degree of Doctor of Philosophy in Chemistry by Sasmita Mishra (Roll Number: 511CY604) Under the supervision of Prof. Saurav Chatterjee February, 2017 Department of Chemistry National Institute of Technology Rourkela Department of Chemistry National Institute of Technology Rourkela Certificate of Examination Roll Number: 511CY604 Name: Sasmita Mishra Title of Dissertation: ''Synthesis and reactivity of cyclopentadienyl based organometallic compounds and their electrochemical and biological properties We the below signed, after checking the dissertation mentioned above and the official record book(s) of the student, hereby state our approval of the dissertation submitted in partial fulfillment of the requirements of the degree of Doctor of Philosophy in Chemistry at National Institute of Technology Rourkela. We are satisfied with the volume, quality, correctness, and originality of the work. --------------------------- Prof. Saurav Chatterjee Principal Supervisor --------------------------- --------------------------- Prof. A. Sahoo. Prof. G. Hota Member (DSC) Member (DSC) --------------------------- -
Zinc Therapy in Dermatology: a Review
Hindawi Publishing Corporation Dermatology Research and Practice Volume 2014, Article ID 709152, 11 pages http://dx.doi.org/10.1155/2014/709152 Review Article Zinc Therapy in Dermatology: A Review Mrinal Gupta, Vikram K. Mahajan, Karaninder S. Mehta, and Pushpinder S. Chauhan DepartmentofDermatology,Venereology&Leprosy,Dr.R.P.Govt.MedicalCollege,Kangra(Tanda),HimachalPradesh176001,India Correspondence should be addressed to Vikram K. Mahajan; [email protected] Received 1 May 2014; Accepted 23 June 2014; Published 10 July 2014 Academic Editor: Craig G. Burkhart Copyright © 2014 Mrinal Gupta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Zinc, both in elemental or in its salt forms, has been used as a therapeutic modality for centuries. Topical preparations like zinc oxide, calamine, or zinc pyrithione have been in use as photoprotecting, soothing agents or as active ingredient of antidandruff shampoos. Its use has expanded manifold over the years for a number of dermatological conditions including infections (leishmaniasis, warts), inflammatory dermatoses (acne vulgaris, rosacea), pigmentary disorders (melasma), and neoplasias (basal cell carcinoma). Although the role of oral zinc is well-established in human zinc deficiency syndromes including acrodermatitis enteropathica, it is only in recent years that importance of zinc as a micronutrient essential for infant